[1] King RJ, Grant PJ. Diabetes and cardiovascular disease:pathophysiology of a life-threatening epidemic[J].Herz, 2016, 41(3):184-192. [2] 张雨薇,周广举,童南伟,等.中国成人糖尿病患者动脉粥样硬化脑心血管疾病分级预防指南解读[J]. 中国实用内科杂志,2016,36(6):453-457. [3] 谢莉萍. 2型糖尿病合并颈动脉硬化斑块形成的相关危险因素分析[J]. 中西医结合心脑血管病杂志, 2017, 15(12):1527-1530. [4] Chróinín DN, Marnane M, Akijian L, et al. Serum lipids associated with inflammation related PET-FDG uptake in symptomatic carotid plaque[J]. Neurology, 2014, 82(19):1693-1699. [5] Inaba Y, Chen JA, Bergmann SR. Carotid plaque compared with carotid intima media thickness more accurately predicts coronary artery disease events:A meta-analysis[J]. Atherosclerosis, 2012, 220(1):128-133. [6] Preiss D, Lloyd SM, Ford I, et al. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study):a randomized controlled trial[J]. Lancet Diabetes Endocrinol, 2014, 2(2):116-124. [7] 陈洁霞, 李结华, 唐海沁, 等. 单核细胞、单核细胞/高密度脂蛋白比值与冠状动脉斑块的相关性研究[J]. 安徽医科大学学报, 2017, 52(8):1223-1226. [8] 陈静宜, 叶子芯, 崔姝雅, 等. 一氧化氮生物利用度失调与动脉粥样硬化[J]. 基础医学与临床, 2017, 37(2):251-255. [9] Vanhoutte PM, Shimokawa H, Feletou M, et al. Endothelial dysfunction and vascular disease-a 30th anniversary update[J]. Acta Physiol(Oxf), 2017, 219(1):22-96. [10] Keles N, Dogan B, Kalcik M, et al. Is serum Klotho protective against atherosclerosis in patients with 1 diabetes mellitus?[J].J Diabet Complications, 2016,30(1):126-132. [11] Gerstein HC, Miller ME. Effects of intensive glycaemic control on ischaemic heart disease authors 7 reply[J]. Lancet, 2015, 385(9974):1180-1181. [12] Jacobson TA, Ito MK, Maki KC, et al. National lipid association recommendations for patient-centered management of dyslipidemia:part 1-full report[J]. J Clin Lipidol, 2015, 9(2):129-169. [13] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南[J]. 中华糖尿病杂志, 2014, 6:447-498. [14] Cetin EH, Cetin MS, Canpolat U, et al. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. Biomarkers Med, 2015, 9(10):967-977. [15] Reddy VS, Bui QT, Jacobs JR, et al. Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox)[J].Am J Cardiol, 2015, 115(5):557-562. [16] Forey BA, Fry JS, Lee PN, et al. The effect of quitting smoking on HDL-cholesterol:a review based on within-subject changes[J]. Biomark Res, 2013, 1:26.doi:10.1186/2050-7771-1-26. [17] Takata K, Imaizumi S, Kawachi E, et al. Impact of cigarette smoking cessation on high-density lipoprotein functionality[J]. Circ J, 2014, 78(12):2955-2962. [18] Hafiane A, Genest J. High density lipoproteins:measurement techniques and potential biomarkers of cardiovascular risk[J]. BBA Clin, 2015, 3:175-188. [19] Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome[J]. Heart Lung Circ, 2016, 25(11):1077-1086. [20] 张智, 黄禄勇, 熊明. 原发性高血压患者血压变异性与颈动脉粥样硬化的关系[J]. 中国医药导报, 2015, 12(29):47-51. [21] Hasegawa H,Inoue T, Tamura A, et al. Emergent intracranial surgical embolectomy in conjunction with carotid endarterectomy for acute internal carotid artery terminus embolic occlusion and tandem occlusion of the cervical carotid artery due to plaque rupture[J]. J Neurosurg, 2015, 122(4):939-947. [22] 裘丽红, 李武艳, 李晓娜, 等. 2型糖尿病合并急性缺血性脑血管病患者颈动脉斑块稳定性及相关因素分析[J]. 中国实用神经疾病杂志, 2013, 16(8):27-29. [23] Osgood K, Krakoff J, Thearle M. Serum uric acid predicts both current and future components of the metabolic syndrome[J]. Metab Syndr Relat Disord, 2013,11(3):157-162. |